IN BRIEF: Oxford BioMedica confirms start date of Mathias as new CEO
Oxford BioMedica PLC - Oxfordshire, England-based gene and cell therapy group - Says Frank Mathias, previously announced as the company's new chief executive officer, will officially join the firm on March 27. Mathias joins Oxford Biomedica from Rentschler Biopharma SE, where he has been CEO since 2016. Read More